Treatment with OPG and cellular gene therapy with IL-4 decrease bone resorption-associated inflammation in collagen-induced arthritis

Similar Items

• Protection of inflammation-related bone loss by OPG and TNF-α antibodies through distinct mechanisms in collagen-induced arthritis
  od: Saidenberg-Kermanach, N, i dr.
  Izdano: (2004)
• Bone sparing effect of osteoprotegerin and anti-inflammatory cytokines in collagen-induced arthritis
  od: de Vernejoul, M, i dr.
  Izdano: (2003)
• AAV mediated delivery of IL-4 prevents collagen-induced arthritis
  od: Bessis, N, i dr.
  Izdano: (2001)
• Nonviral gene therapy by electrotransfer of hTNF-α soluble receptor variants: application to the treatment of collagen arthritis
  od: Bloquel, C, i dr.
  Izdano: (2004)
• Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA)
  od: Bessis, N, i dr.
  Izdano: (1999)